A Study on the Metabolite Changes in Brain Diseases: 3 Teslar 1H Magnetic Resonance Spectroscopy

뇌질환 대사물질 변화의 고찰; 3 Teslar 수소 자기공명분광법

  • 은성종 (한려대학교 방사선학과) ;
  • 김정재 (한려대학교 대학원 보건학과정) ;
  • 유승철 (한려대학교 대학원 보건학과정)
  • Received : 2014.01.08
  • Accepted : 2013.01.25
  • Published : 2014.01.30


The purpose of this study is to know the differences of metabolism in abnormal brain disease using a single-voxel proton MR spectroscopy(1H MRS) Together with five normal volunteers and each five patients with brain diseases, pathologically proved, underwent MRI and 1H MRS. The quantitative results of 1H MRS in adrenoleukodystrophy(ALD), hepatic encephalopathy(HE), and infarction gave unique information on the metabolite changes related with the white matter: the concentration of NAA decreased in all diseases; Cho, mI and Lac increased in ALD; Cho decreased in HE; and ${\beta}{\cdot}{\gamma}$-Glx and Lac increased in infarction. It is concluded that 1H MRS is capable of diagnosing brain diseases by monitoring metabolite changes in vivo that subsequently develope into abnormalities. 1H MRS may be a useful clinical tool for in both diagnosis and prognosis of brain diseases.

본 연구의 목적은 단일 복셀 자기공명 분광법을 이용하여 비정상적인 뇌질환을 가진 환자의 뇌대사물질이 어떻게 다른지를 알아보는데 있다. 수소 자기공명분광법의 정량적 분석의 결과 부신백질이영양증, 간선뇌병증, 뇌경색은 백질에 관련된 대사물질에 변화를 보였다. 세질환 모두 NAA가 감소하였고, ALD에서는 Cho, mI 과 Lac가 증가하였고, 간성뇌병변에서는 Cho가 감소, 그리고 뇌경색에서는 ${\beta}{\cdot}{\gamma}$-Glx와 Lac가 증가되었다. 결론적으로 수소 자기공명분광법은 비정상적으로 발전하는 뇌질환의 대사물질의 변화를 관찰하여 병을 진단할 수 있고 이는 임상에서 뇌질환의 진단과 예후를 평가하는데 유용할 것이다.



  1. Magnetic Resonance Imaging. NIH consens Statement, Vol. 6, No. 14, pp. 1-31, 1987.
  2. Joseph P., Hornak, Ph.D., "The Basic of MRI. Rochester Institute of Technology", 1987.
  3. Lehninger A.L., Nelson D.L., Cox M.M., "Principles of Biochemistry", 2ed ed. New York: Worth Publishers, pp. 1-81, 1993.
  4. Stark D.D., Bradely W.G., "Magnetic Resonance Imaging", 2nd ed. St. Louise, Mosby-Year Book, pp. 88-144, 1992.
  5. Westbrook C., "Handbook of MRI Technique. Oxford: Blackwell Science", pp. 15-26, 1994.
  6. Bottomley D.A., "Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology", Vol. 170, pp. 1-15, 1989.
  7. Choi B.Y., "MR spectroscopy. korean scciety of magnetic resonance", Vol. 1, pp. 1-13, 1997.
  8. Grant D.H., Harris R.K., "Encydopedia of nuclear magnetic resonance", Hohn Wiley & sons Ltd England, 1996.
  9. Ross B., Hreis R., Ernst T., "Clinical tools for the 90s:magnetic resonance spectroscopy and metabolite imaging". Eur J Radiol., Vol. 14, pp. 128-140, 1992.
  10. Henriksen O., "MR spectroscopy in clinical research". Acta Radiogica., Vol. 35, pp. 96-116, 1994.
  11. Ross B., Michaelis T., "Clinical applications of magnetic resonance spectroscopy", Magn Reson Quart, .Vol. 10, pp. 191-247, 1994.
  12. Ross B.D., "The biochemistry of living tissues: examination by MRS", NMR in Biomedicine", Vol. 5, pp. 215-219, 1992.
  13. Cousins J.P., "Clinical MR spectroscopy : fundamentals, current applications, and future potential", Am J Roentgenol. Vol. 164, pp. 1337-1347, 1995.
  14. Matson G.B., Weiner M.W., "Spectroscopy. In Stark DB, Bradley WG Jr. Magnetic Resonance Imaging", 3rd ed. St. Louis : Mosby, pp. 181-214, 1999.
  15. Bolinger L., Insko E.K., "Spectroscopy: basic principles and techniques. In Edelman RR, Zlatkin MB, Hesselink JR. Clinical Magnetic Resonance Imaging", 2nd ed. Philadelphia; Saunders, pp. 928-981, 1996.
  16. Howe F.A., Maxwell R.J., Saunders D.E., Brown M.M., Griffiths J.R., "Proton spectroscopy in vivo. Magn Reson Quert", Vol. 9, pp. 31-59, 1993.
  17. Merchant T.E., "MR spectroscopy of the breast", Magn Reson Imaging Clin N Am., Vol. 2, pp. 691-703, 1994.
  18. Ordridge R.J., Connelly A., Lohman JAB., "Image selected in vivo spectroscopy: A new technique for spatially selective NMR spectroscopy", J Magn Reson., Vol. 66, pp. 284-294, 1986.
  19. Luyten P.R., den Hollander J.A.. "1H MR spatially resolved spectroscopy of human tissues in situ.", Magn Reson Imaging, Vol. 4, pp. 237-239, 1986.
  20. Aue W.P., "Localization methods for in vivo NMR spectroscopy", Rev Magn Reson Med, Vol. 1, pp. 21-72, 1986.
  21. Christiansen P., Henriksen O., Stubgaard M., Gideon P., Larsson H.B., "In vivo quantification of brain metabolites by 1H MRS using water as an internal standard", Magn Reson Imaging, Vol. 11, pp. 107-118, 1993.
  22. J.S. Ryu, K.J. Kim, et al., "Clinical approch of ADLwith MRI", KSMRM, Vol. 1, pp. 50-63, 1993.
  23. Kreis R., Ross B., Farrow N., Ackerman B., "Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy", Radiology. Vol. 182, pp. 19-27, 1992.
  24. Duijn J.H., Matson G.B., Maudsley A.A., Hugg J.W., Weiner M.W., "Human brain infarction: Proton MR spectroscopy", Radiology, Vol. 183, pp. 711-718, 1992.
  25. Jussi Pekka R., Usenius, Risto A., Kauppinen, Pauli A., Vainio, Juha A., Hernesniemi, Matti P., Vapalahti, Les A., Paljarvi, Seppo Soimakallo, "Quantitative metabolite patterns of human brain tumors: Detection by 1H NMR spectroscopy in vivo and in vitro", J Computer Assisted Tomography, Vol. 18, No.5, pp. 705-713, 1994.
  26. Laprie A., Catalaa I., Cassol E., et al., "Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study", Int J Radiat Oncol Biol Phys., Vol. 70, No.3, pp.773-781, 2008.
  27. Murphy P.S., Viviers L., Abson C., et al., "Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy", Br J Cancer. Vol. 90, No. 4, pp. 781-786, 2004.

Cited by

  1. A Study on Optimized MRI Fat-Saturation Technique for Brachial Plexus Patients : Focused on SPAIR and STIR Fat-Saturation vol.8, pp.5, 2014,